Category Specific RSS

Opinion

Fast Money: KMD Brands (KMD) Vs Calidus Resources (CAI)

In the current economic climate, would you rather invest in an outdoor apparel retailer that can capitalise on the resumption of international travel and no COVID sales interruption in 12 months, or a gold miner trading at about Net Tangible Assets (NTA) levels with operational activities around the corner? 

Emerald Financial analysts Sam Green and Alfred Chan each have 60 seconds to put their case forward on a stock on the ASX that they are keeping a close eye on. In this edition, they slug out a battle between KMD Brands (ASX: KMD) and Calidus Resources (ASX: CAI). 

Having added Rip Curl to its portfolio in addition to the existing Kathmandu brand, KMD made $550 million sales in the December half and is back to profitability with $14m net profit, while also paying dividends. It is currently focusing its Rip Curl expansion into the North American market which is about to enter Summer.

Meanwhile, WA-based Calidus has been starting a bit below its previously suggested numbers, but has observed some improvements as gold production is starting to increase. It is forecast to last six months with sustainable production costs around $2,300 per ounce, while the spot price of gold has just reached $3,000.

Keen for more details? Watch below:

For more videos like this, click here to visit the Emerald Financial Youtube channel to subscribe.

Emerald Financial

Emerald Financial is a financial services firm founded in 2005. We offer a diversified range of services, including; stock research and data, education courses, portfolio services, and financial news. Over the years, we have educated thousands of Australians to trade equities and derivative markets.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago